Ariel Investments, an investment management company, released its “Ariel Focus Fund” Q3 2026 investor letter. A copy of the letter can be downloaded here. The Fund declined during the third quarter of ...
StockStory.org on MSN
Dentsply Sirona (XRAY): Buy, sell, or hold post Q2 earnings?
Dentsply Sirona has gotten torched over the last six months - since April 2026, its stock price has dropped 27.3% to $8.62 per share. This may have investors wondering how to approach the situation.
Dentsply Sirona (XRAY) stock outlook: revenue declines, weak cash flow, and 3.4x leverage despite cheap valuation—see why ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Management reaffirmed the full-year 2025 guidance for organic sales to decline by 2%-4% and adjusted EPS to remain in the range of $1.80 to $2. Reported sales guidance was revised upward to $3.6 ...
Zacks Investment Research on MSN
Dentsply Sirona expands US digital dentistry reach with Midwest deal
Dentsply Sirona XRAY recently announced expansion of its U.S. commercial reach through an enhanced distribution agreement with Midwest Dental Equipment & Supply. Effective Nov. 1, 2026, the ...
CHARLOTTE, N.C., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona (Nasdaq: XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced an ...
A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call. Dentsply Sirona is the world’s largest diversified manufacturer of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results